Does Cymbalta Have A Moa Inhibitor?
Pronounced: (dull-OX-eh-teen)
Uses
Duloxetine is used to treat major depression and anxiety. In addition, duloxetine is used to relieve nerve pain (peripheral neuropathy) in people with diabetes. It is also used to treat pain caused by a condition called fibromyalgia that affects the muscles, tendons, ligaments, and supporting tissues.
This medication is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by helping to restore the balance of...
Read moreMore information on "Does Cymbalta Have A Moa Inhibitor?"
From Our Experts
Antidepressants: Cymbalta
You've probably seen the television commercials or magazine ads for Cymbalta, and you might be wondering what makes it different from other... Read more »
A Comparison of Fibromyalgia Medications: Lyrica, Cymbalta and Savella
As of this writing, three medications have been approved by the FDA for the treatment of fibromyalgia: Lyrica (pregabalin), Cymbalta... Read more »
Fibromyalgia Research Looks at Milnacipran and Cymbalta
The sessions on fibromyalgia were rather popular at last week's American College of Rheumatology (ACR) Annual Scientific Meeting in San... Read more »
Will Cymbalta Become the Second Drug Approved for Fibromyalgia?
Eli Lilly and Co. recently submitted a supplemental new drug application to the U.S. Food and Drug Administration requesting that Cymbalta... Read more »
Cymbalta Approved for Fibromyalgia
Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first... Read more »
From Our Sources
Study: Escitalopram better than Cymbalta for MDD
A new study suggests that the antidepressant escitalopram (Cipralex, Lexapro) is better at treating symptoms of major depressive disorder than... Read more »
Clinical trial: Cymbalta for MS-related pain
This is a study to evaluate the safety and effectiveness of Cymbalta compared to a placebo in treating pain in people who have multiple sclerosis... Read more »
Cymbalta's chronic pain application withdrawn--for now
Drugmaker Eli Lilly and Co. withdrew its application to the U.S. Food and Drug Administration for its antidepressant Cymbalta to be approved for use... Read more »
Clinical Trial: Cymbalta for Multiple Sclerosis Pain
This is a study to determine the safety and effectiveness of different doses of Cymbalta (duloxetine) compared to a placebo in reducing pain in... Read more »
Cymbalta maintains chronic pain relief: study
Drugmaker Eli Lilly is reporting that its drug Cymbalta was effective at the long-term reduction of chronic low back pain in a new study. For the... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
